Astec LifeSciences Limited — Important, 23-04-2025: Disclosure of material issue

A material issue has emerged related to the company's supply chain disruptions, primarily attributed to certain vendor challenges affecting raw material availability. This situation could lead to delays in production schedules and might impact revenue forecasts for the upcoming quarters. The company is actively engaging with alternative suppliers to mitigate the risks and restore normal operations. Immediate actions include a review of existing contracts and strengthening relationships with key vendors. Stakeholders should monitor this situation closely, as it may influence overall business performance.